An exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists

Background: The NHLBI has not developed clinical practice guidelines since 2007. As a result, multiple organizations have released competing guidelines. This has created confusion and debate among clinicians as to which recommendations are most applicable for practice. Objectives: To explore prelimi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jessica M. Downes, Lisa A. Appeddu, Jeremy L. Johnson, Kelsey S. Haywood, B. Jordan James, Kendrick D. Wingard
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Hypertension Dyslipidemia Asthma Practice guideline NHLBI National Heart Lung and blood institute Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/9dd95794058c4715a71d6d253fd3cd13
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9dd95794058c4715a71d6d253fd3cd13
record_format	dspace
spelling	oai:doaj.org-article:9dd95794058c4715a71d6d253fd3cd132021-11-04T04:44:38ZAn exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists2667-276610.1016/j.rcsop.2021.100013https://doaj.org/article/9dd95794058c4715a71d6d253fd3cd132021-06-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667276621000135https://doaj.org/toc/2667-2766Background: The NHLBI has not developed clinical practice guidelines since 2007. As a result, multiple organizations have released competing guidelines. This has created confusion and debate among clinicians as to which recommendations are most applicable for practice. Objectives: To explore preliminary attitudes, awareness, and usage of clinical practice guidelines in practice and teaching for hypertension, dyslipidemia and asthma among clinical pharmacists. Methods: Clinical pharmacists across the US were surveyed electronically over a two week period in Spring 2019 regarding utilization and knowledge of practice guidelines for hypertension, dyslipidemia, and asthma. Clinical cases were included to evaluate application of guidelines. Descriptive statistics, Chi-square analysis, and Wilcoxon signed-rank test were conducted. Statistical significance level was set to 0.01 to account for multiple tests conducted on the same survey participants. Results: Forty-eight, 34, and 28 pharmacists voluntarily completed hypertension, dyslipidemia, and asthma survey questions, respectively. Interactions by disease state (p < 0.001) revealed more pharmacists (93%) reporting to have ≤50% patient load in managing asthma and more pharmacists (95%) had read the full summary/report of the most recent hypertension guideline. Primary reasons why the most recent guideline was not selected were also significantly different by disease state (interaction; p < 0.001). For dyslipidemia and asthma, pharmacists had a higher mean rating of agreement (p < 0.007) in having the most confidence in the most recent as compared to older guidelines. Proportionally more clinical cases were answered correctly (interaction; p < 0.001) when pharmacists applied the most recent guideline for hypertension (84%), while the opposite outcome was found for asthma (27%). Conclusion: While more pharmacists selected the most recent guideline for practice and teaching, there was inconsistent application of guidelines to clinical cases. Further studies with a larger representation of pharmacists are warranted to more definitively determine factors influencing guideline preference and usage.Jessica M. DownesLisa A. AppedduJeremy L. JohnsonKelsey S. HaywoodB. Jordan JamesKendrick D. WingardElsevierarticleHypertensionDyslipidemiaAsthmaPractice guidelineNHLBINational Heart Lung and blood institutePharmacy and materia medicaRS1-441ENExploratory Research in Clinical and Social Pharmacy, Vol 2, Iss , Pp 100013- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Hypertension Dyslipidemia Asthma Practice guideline NHLBI National Heart Lung and blood institute Pharmacy and materia medica RS1-441
spellingShingle	Hypertension Dyslipidemia Asthma Practice guideline NHLBI National Heart Lung and blood institute Pharmacy and materia medica RS1-441 Jessica M. Downes Lisa A. Appeddu Jeremy L. Johnson Kelsey S. Haywood B. Jordan James Kendrick D. Wingard An exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists
description	Background: The NHLBI has not developed clinical practice guidelines since 2007. As a result, multiple organizations have released competing guidelines. This has created confusion and debate among clinicians as to which recommendations are most applicable for practice. Objectives: To explore preliminary attitudes, awareness, and usage of clinical practice guidelines in practice and teaching for hypertension, dyslipidemia and asthma among clinical pharmacists. Methods: Clinical pharmacists across the US were surveyed electronically over a two week period in Spring 2019 regarding utilization and knowledge of practice guidelines for hypertension, dyslipidemia, and asthma. Clinical cases were included to evaluate application of guidelines. Descriptive statistics, Chi-square analysis, and Wilcoxon signed-rank test were conducted. Statistical significance level was set to 0.01 to account for multiple tests conducted on the same survey participants. Results: Forty-eight, 34, and 28 pharmacists voluntarily completed hypertension, dyslipidemia, and asthma survey questions, respectively. Interactions by disease state (p < 0.001) revealed more pharmacists (93%) reporting to have ≤50% patient load in managing asthma and more pharmacists (95%) had read the full summary/report of the most recent hypertension guideline. Primary reasons why the most recent guideline was not selected were also significantly different by disease state (interaction; p < 0.001). For dyslipidemia and asthma, pharmacists had a higher mean rating of agreement (p < 0.007) in having the most confidence in the most recent as compared to older guidelines. Proportionally more clinical cases were answered correctly (interaction; p < 0.001) when pharmacists applied the most recent guideline for hypertension (84%), while the opposite outcome was found for asthma (27%). Conclusion: While more pharmacists selected the most recent guideline for practice and teaching, there was inconsistent application of guidelines to clinical cases. Further studies with a larger representation of pharmacists are warranted to more definitively determine factors influencing guideline preference and usage.
format	article
author	Jessica M. Downes Lisa A. Appeddu Jeremy L. Johnson Kelsey S. Haywood B. Jordan James Kendrick D. Wingard
author_facet	Jessica M. Downes Lisa A. Appeddu Jeremy L. Johnson Kelsey S. Haywood B. Jordan James Kendrick D. Wingard
author_sort	Jessica M. Downes
title	An exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists
title_short	An exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists
title_full	An exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists
title_fullStr	An exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists
title_full_unstemmed	An exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists
title_sort	exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/9dd95794058c4715a71d6d253fd3cd13
work_keys_str_mv	AT jessicamdownes anexploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT lisaaappeddu anexploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT jeremyljohnson anexploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT kelseyshaywood anexploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT bjordanjames anexploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT kendrickdwingard anexploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT jessicamdownes exploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT lisaaappeddu exploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT jeremyljohnson exploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT kelseyshaywood exploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT bjordanjames exploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists AT kendrickdwingard exploratorysurveyontheawarenessandusageofclinicalpracticeguidelinesamongclinicalpharmacists
_version_	1718445228890783744

An exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists

Ejemplares similares